Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Inhibiteur histone deacetylase")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1494

  • Page / 60

Export

Selection :

  • and

Histone Deacetylase Inhibitors Promote the Tumoricidal Effect of HAMLETBREST, Patrick; GUSTAFSSON, Mattias; MOSSBERG, Ann-Kristin et al.Cancer research (Baltimore). 2007, Vol 67, Num 23, pp 11327-11334, issn 0008-5472, 8 p.Article

Radiosensitization by the Histone Deacetylase Inhibitor PCI-24781BANUELOS, Carmen A; BANATH, Judit P; MACPHAIL, Susan H et al.Clinical cancer research. 2007, Vol 13, Num 22, pp 6816-6826, issn 1078-0432, 11 p., 1Article

Histone Deacetylase Inhibitor Enhances Recovery after AKICIANCIOLO COSENTINO, Chiara; SKRYPNYK, Nataliya I; DAVIDSON, Alan J et al.Journal of the American Society of Nephrology. 2013, Vol 24, Num 6, pp 943-953, issn 1046-6673, 11 p.Article

Romidepsin for Cutaneous T-cell LymphomaMILES PRINCE, H; DICKINSON, Michael.Clinical cancer research (Print). 2012, Vol 18, Num 13, pp 3509-3515, issn 1078-0432, 7 p.Article

Antimalarial Activity of the Anticancer Histone Deacetylase Inhibitor SB939SUMANADASA, Subathdrage D. M; GOODMAN, Christopher D; LUCKE, Andrew J et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 7, pp 3849-3856, issn 0066-4804, 8 p.Article

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexesBANTSCHEFF, Marcus; HOPF, Carsten; BOESCHE, Markus et al.Nature biotechnology (Print). 2011, Vol 29, Num 3, pp 255-265, issn 1087-0156, 11 p.Article

Histone deacetylase inhibitors induce premature sister chromatid separation and override the mitotic spindle assembly checkpointMAGNAGHI-JAULIN, Laura; EOT-HOULLIER, Grégory; FULCRAND, Géraldine et al.Cancer research (Baltimore). 2007, Vol 67, Num 13, pp 6360-6367, issn 0008-5472, 8 p.Article

La protéine TRAIL induit spécifiquement l'apoptose des cellules cancéreuses = Induction of tumor cells apoptosis by TRAIL proteinANDUJAR, Gauthier.Biofutur (Puteaux). 2005, Num 256, issn 0294-3506, p. 13Article

Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor―induced thrombocytopeniaBISHTON, Mark J; HARRISON, Simon J; MARTIN, Benjamin P et al.Blood. 2011, Vol 117, Num 13, pp 3658-3668, issn 0006-4971, 11 p.Article

Histone deacetylase inhibitors and a functional potent inhibitory effect on human uterine contractilityMOYNIHAN, Audrey T; HEHIR, Mark P; SHARKEY, Aidan M et al.American journal of obstetrics and gynecology. 2008, Vol 199, Num 2, pp 167-169, issn 0002-9378, 3 p.Article

Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Spl transcription factorCUCCIOLLA, Valeria; BORRIELLO, Adriana; CRISCUOLO, Maria et al.Carcinogenesis (New York. Print). 2008, Vol 29, Num 3, pp 560-567, issn 0143-3334, 8 p.Article

Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formationSTIEHL, Daniel P; PATH, Donna M; DONGMING LIANG et al.Cancer research (Baltimore). 2007, Vol 67, Num 5, pp 2256-2264, issn 0008-5472, 9 p.Article

Histone deacetylase inhibitors-turning epigenic mechanisms of gene regulation into tools of therapeutic intervention in malignant and other diseasesRIESTER, Daniel; HILDMANN, Christian; SCHWIENHORST, Andreas et al.Applied microbiology and biotechnology. 2007, Vol 75, Num 3, pp 499-514, issn 0175-7598, 16 p.Article

Mechanisms of Resistance to Histone Deacetylase Inhibitors and Their Therapeutic ImplicationsFANTIN, Valeria R; RICHON, Victoria M.Clinical cancer research. 2007, Vol 13, Num 24, pp 7237-7242, issn 1078-0432, 6 p.Article

Dimethyl sulfoxide to vorinostat : development of this histone deacetylase inhibitor as an anticancer drugMARKS, Paul A; BRESLOW, Ronald.Nature biotechnology (Print). 2007, Vol 25, Num 1, pp 84-90, issn 1087-0156, 7 p.Article

Histone Deacetylase Inhibitors in Cancer TherapyLANE, Andrew A; CHABNER, Bruce A.Journal of clinical oncology. 2009, Vol 27, Num 32, pp 5459-5468, issn 0732-183X, 10 p.Article

Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspinXIAOHUA LI; SHUPING YIN; YONGHONG MENG et al.Cancer research (Baltimore). 2006, Vol 66, Num 18, pp 9323-9329, issn 0008-5472, 7 p.Article

Potent Antimalarial Activity of Histone Deacetylase Inhibitor AnaloguesANDREWS, K. T; TRAN, T. N; LUCKE, A. J et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 4, pp 1454-1461, issn 0066-4804, 8 p.Article

Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasmsGORE, Steven D; BAYLIN, Stephen; RUDEK, Michelle A et al.Cancer research (Baltimore). 2006, Vol 66, Num 12, pp 6361-6369, issn 0008-5472, 9 p.Article

SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylasesTHANGARAJU, Muthusamy; GOPAL, Elangovan; MARTIN, Pamela M et al.Cancer research (Baltimore). 2006, Vol 66, Num 24, pp 11560-11564, issn 0008-5472, 5 p.Article

Induction of polyploidy by histone deacetylase inhibitor : A pathway for antitumor effectsXU, Wei-Sheng; PEREZ, Gisela; NGO, Lang et al.Cancer research (Baltimore). 2005, Vol 65, Num 17, pp 7832-7839, issn 0008-5472, 8 p.Article

Histone deacetylase inhibition-mediated differentiation of RGC-5 cells and interaction with survivalSCHWECHTER, Brandon R; MILLET, Lucia E; LEVIN, Leonard A et al.Investigative ophthalmology & visual science. 2007, Vol 48, Num 6, pp 2845-2857, issn 0146-0404, 13 p.Article

Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseasesBLANCHARD, Frédéric; CHIPOY, Céline.Drug discovery today. 2005, Vol 10, Num 3, pp 197-204, issn 1359-6446, 8 p.Article

Enhancement of xenograft tumor radiosensitivity by the Histone deacetylase inhibitor MS-275 and correlation with Histone hyperacetylationCAMPHAUSEN, Kevin; SCOTT, Tamalee; SPROULL, Mary et al.Clinical cancer research. 2004, Vol 10, Num 18, pp 6066-6071, issn 1078-0432, 6 p.Article

Depletion of Embryonic Stem Cell Signature by Histone Deacetylase inhibitor in NCCIT Cells: Involvement of Nanog SuppressionJUENG SOO YOU; JAE KU KANG; SEO, Dong-Wan et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 14, pp 5716-5725, issn 0008-5472, 10 p.Article

  • Page / 60